Fundz

Cardiff Oncology Appoints Dr. Roger Sidhu as Chief Medical Officer

PUBLIC · CRDFJun 17, 2025

Position

Chief Medical Officer

Company

Cardiff Oncology

Roger Sidhu
rsidhu@cardiffoncology.com
San DiegoBiotechnologyHealth CareScience And Engineering

Description

Cardiff Oncology has announced the appointment of Dr Roger Sidhu as their new Chief Medical Officer, succeeding Dr Fairooz Kabbinavar. Dr Sidhu brings over 20 years of experience in oncology leadership, particularly in metastatic colorectal cancer clinical trials.

Quick answer

Cardiff Oncology Appoints Dr. Roger Sidhu as Chief Medical Officer (June 17, 2025). Cardiff Oncology is based in San Diego, California, United States.

Who is the new Chief Medical Officer at Cardiff Oncology?
Cardiff Oncology named Roger Sidhu Chief Medical Officer, announced June 17, 2025.
What did Cardiff Oncology announce on June 17, 2025?
Cardiff Oncology has announced the appointment of Dr Roger Sidhu as their new Chief Medical Officer, succeeding Dr Fairooz Kabbinavar. Dr Sidhu brings over 20 years of experience in oncology leadership, particularly in metastatic colorectal cancer clinical trials.
What does Cardiff Oncology do?
Cardiff Oncology is a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-validated oncology drug target, to develop novel therapies across a range of cancers.
Where is Cardiff Oncology based?
Cardiff Oncology is based in San Diego, California, United States.
Which similar companies made leadership changes around the same time?
Kyverna Therapeutics (June 30, 2025), Upstream Bio (May 20, 2025), The Hain Celestial Group (May 7, 2025) and Unlearn (July 29, 2025) also announced leadership changes within 45 days of Cardiff Oncology.

Source: Fundz verified event record.

Other recent leadership changes in Science And Engineering and Biotechnology

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Cardiff Oncology, and when

A new leader at Cardiff Oncology brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Cardiff Oncology raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Cardiff Oncology, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Cardiff Oncology. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Cardiff Oncology

Location

11055 Flintkote Avenue

San Diego, California, United States

About

Cardiff Oncology is a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-validated oncology drug target, to develop novel therapies across a range of cancers. The Company's lead asset is onvansertib, a PLK1 inhibitor being evaluated in combination with standard of care (SoC) therapeutics in clinical programs targeting indications such as RAS-mutated metastatic colorectal cancer (mCRC), as well as in ongoing and planned investigator-initiated trials in metastatic pancreatic ductal adenocarcinoma (mPDAC), small cell lung cancer (SCLC) and triple negative breast cancer (TNBC). These programs and the Company's broader development strategy are designed to target tumor vulnerabilities in order to overcome treatment resistance and deliver superior clinical benefit compared to the SoC alone.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Cardiff Oncology changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Roger
Likely contact at this company
••••••••@••••••••

See Roger's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Cardiff Oncology's next move

Learn about Strategic plan

Cardiff Oncology changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.